Adverum Biotechnologies, Inc. (LON:0HA3)
London · Delayed Price · Currency is GBP · Price in USD 4.288
+0.069 (1.64%)
At close: Oct 31, 2025
Adverum Biotechnologies Market Cap
Adverum Biotechnologies has a market cap or net worth of 68.7 million as of November 3, 2025. Its market cap has decreased by -47.69% in one year.
Market Cap
68.70M
Enterprise Value
105.11M
Revenue
729.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.29
Market Cap Chart
Since August 1, 2014, Adverum Biotechnologies's market cap has decreased from 319.27M to 68.70M, a decrease of -78.48%. That is a compound annual growth rate of -12.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 68.70M | -11.47% |
| Dec 31, 2024 | 77.60M | 29.96% |
| Dec 29, 2023 | 59.71M | 24.48% |
| Dec 30, 2022 | 47.97M | -62.40% |
| Dec 31, 2021 | 127.58M | -83.52% |
| Dec 31, 2020 | 773.94M | 37.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 191.73B |
| HSBC Holdings | 183.56B |
| Shell | 164.27B |
| Unilever | 114.25B |
| Rolls-Royce Holdings | 98.20B |
| Rio Tinto Group | 93.27B |
| British American Tobacco p.l.c. | 84.99B |
| GSK plc | 71.57B |